Crescent Biopharma, Inc. (CBIO)
NASDAQ · Healthcare
Crescent Biopharma, Inc. Price to Book Ratio 2014–2026
Price to book (P/B) ratio for Crescent Biopharma, Inc. (CBIO): market cap divided by shareholder equity. As of March 31, 2026 it is 2.49.
From: 03/31/2014To: 03/31/2026
Stock Price
Book Value
Price to Book
Crescent Biopharma, Inc. Price to Book Ratio — FAQ
Crescent Biopharma, Inc. (CBIO) price to book ratio over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CBIO's price to book ratio history?
The chart and table above show Crescent Biopharma, Inc.'s price to book ratio by year and by quarter, including the growth rate.